Radin: On-demand cloud bio infrastructure gives startups big-pharma capabilities
Andrew Radin · a16z Podcast | Move Fast But Don't Break Things (When It Comes to Computational Biology) · Jan 2, 2019 · at 3:26
Andrew Radin is the co-founder and CEO of TwoXAR. He describes how on-demand cloud computing and outsourced lab services equalize capabilities between biopharma startups and major pharmaceutical firms.
0:00 / 0:28exact quote · 28.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“And so we acquire resources on demand. And so this ability to go out and get millions, if not tens of millions of dollars worth of infrastructure, whether that's computer, whether that's lab resources use it in that, that moment. And that moment might be 10 minutes worth of computation and then release that resource and don't have to pay for it again. That enables startups and small companies to do things, to have all the types of resources that the big guys have without having to have the huge bank account.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Andrew Radin
Radin: Computer simulations will eventually replace animal models in drug testing
“And so when we look at some of the data models and what we can do in terms of the predictive power of those models, you know, I see a future where we're getting rid of the animals, because what we can simulate in the computer is going to do a better job of pre…”